Altria announces delay in US Iqos rollout, posts revenue boost for oral tobacco

Altria has presented positive numbers for the first half of the year, while also announcing a delay in further expansion of Iqos consumables in the US until a patent infringement case is resolved...
Unlock access

Want the full analysis? Let's talk

We share insights with professionals we’re in contact with. Let us know a bit about your interest.

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Name*

Want the full analysis? Let's talk

We share insights with professionals we’re in contact with. Let us know a bit about your interest.

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Name*